Decoding the Science: The Role of Molecular Profiling and Genomics in Glioblastoma Multiforme Treatment
The evolution of Glioblastoma Multiforme (GBM) treatment is deeply rooted in the advancements of molecular and genomic Glioblastoma Multiforme Market research. Once viewed as a singular, uniformly aggressive disease, GBM is now understood as a highly heterogeneous tumor with distinct molecular subtypes—classical, mesenchymal, and proneural—each characterized by specific genetic...
0 Comments 0 Shares 114 Views 0 Reviews